Profil
Bernardus N.
M.
MacHielse is currently the Chairman at Polyneuron Pharmaceuticals AG, Director at Redwood Holding SA, and Director at F3 Platform Biologics, Inc. He previously held positions as President, Chief Executive Officer & Director at Vtesse, Inc., Director at Xencor, Inc., Director at AbCellera Boston, Inc., Quality Director at Janssen Biologics BV, Executive Vice President-Operations at MedImmune LLC, Vice President-Quality Assurance & Control at XOMA Corp., and Chief Operating Officer & Executive Vice President at Omthera Pharmaceuticals, Inc. He received his undergraduate and graduate degrees from the University of Utrecht.
Postes actifs de Bernardus MacHielse
| Sociétés | Poste | Début |
|---|---|---|
| REDWOOD HOLDING S.A. | Directeur/Membre du Conseil | 01/01/2018 |
F3 Platform Biologics, Inc.
F3 Platform Biologics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops novel therapeutics | Directeur/Membre du Conseil | - |
Anciens postes connus de Bernardus MacHielse
| Sociétés | Poste | Fin |
|---|---|---|
Omthera Pharmaceuticals, Inc.
Omthera Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as pharmaceuticals company which focuses on the clinical development of new therapies for dyslipidemia | Directeur des opérations | 01/08/2013 |
Vtesse, Inc.
Vtesse, Inc. BiotechnologyHealth Technology Engages in pre-clinical and clinical studies and develops drugs for patients suffering from diseases | Directeur Général | - |
Polyneuron Pharmaceuticals AG
Polyneuron Pharmaceuticals AG Pharmaceuticals: MajorHealth Technology Develops drugs for the treatment of autoimmune disorders | Président | - |
Janssen Biologics BV
Janssen Biologics BV Pharmaceuticals: MajorHealth Technology Manufactures, acquires and markets biopharmaceutical therapies | Corporate Officer/Principal | - |
| XOMA ROYALTY CORPORATION | Corporate Officer/Principal | - |
Formation de Bernardus MacHielse
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 11 |
|---|---|
MedImmune LLC
MedImmune LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
XOMA Royalty Corp.
XOMA Royalty Corp. Pharmaceuticals: MajorHealth Technology Discovers and develops antibody therapeutics | Health Technology |
Xencor, Inc.
Xencor, Inc. BiotechnologyHealth Technology Develops therapeutics to treat autoimmune and allergic diseases, cancer and other conditions | Health Technology |
AbCellera Boston, Inc.
AbCellera Boston, Inc. BiotechnologyHealth Technology Produces vaccines for plant, animal and human diseases | Health Technology |
Omthera Pharmaceuticals, Inc.
Omthera Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as pharmaceuticals company which focuses on the clinical development of new therapies for dyslipidemia | Health Technology |
University of Utrecht
University of Utrecht Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Redwood Holding SA
Redwood Holding SA Metal FabricationProducer Manufacturing Manufactures and distributes bearings and machine components | Producer Manufacturing |
Janssen Biologics BV
Janssen Biologics BV Pharmaceuticals: MajorHealth Technology Manufactures, acquires and markets biopharmaceutical therapies | Health Technology |
Vtesse, Inc.
Vtesse, Inc. BiotechnologyHealth Technology Engages in pre-clinical and clinical studies and develops drugs for patients suffering from diseases | Health Technology |
Polyneuron Pharmaceuticals AG
Polyneuron Pharmaceuticals AG Pharmaceuticals: MajorHealth Technology Develops drugs for the treatment of autoimmune disorders | Health Technology |
F3 Platform Biologics, Inc.
F3 Platform Biologics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops novel therapeutics | Health Technology |
















